Biotech entity
Of the tracked stories, 1 of 2 also mention American Medical Association, the most common co-covered peer. The 41-day window averages about 0.3 stories each week. The 5 average consequence score is below the beat benchmark of 5.6 in the same window.
Last mentioned: 6d ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 1 of 2 also mention American Medical Association, the most common co-covered peer. The 41-day window averages about 0.3 stories each week. The 5 average consequence score is below the beat benchmark of 5.6 in the same window. The clearest coverage concentration is fda-approval: 1 of 2 stories, with the rest divided among 1 other category. Source depth averages 2 original sources per story, versus 2.3 across the same-window beat baseline. We currently track 2 Biotech stories that mention Novavax, published between August 4, 2026 and September 13, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 141 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Novavax. Shared-story counts are live from our verified record — not editorial picks.
The FDA has cleared updated COVID-19 vaccines from Pfizer, Moderna, and Novavax for 2026-27, targeting the XFG/Stratus strain. The decision resets the competitive landscape for seasonal vaccine makers.
Source: eastbaytimes.com · marinij.com
Novavax was slapped with a sell rating by Wall Street Zen, even after beating Q1 revenue estimates by 49%. The downgrade highlights biotech skepticism toward small-cap vaccine players in a shifting market.
Source: dailypolitical.com · tickerreport.com
Novavax is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
